Artivion, Intuitive Surgical, GE HealthCare, LeMaitre, and Globus Medical Shares Plummet, What You Need To Know

What Happened?

A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as investors reacted to escalating uncertainty tied to the U.S.-Iran conflict and policy deadlines set by the Trump administration. Markets dislike unpredictability, and these fears were amplified, raising concerns of prolonged conflict and rising oil prices. This negative outlook reflected in consumer confidence, with the University of Michigan's sentiment index sliding to a three-month low.

The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks.

Among others, the following stocks were impacted:

• Medical Devices & Supplies - Cardiology, Neurology, Vascular company Artivion (NYSE:AORT) fell 2.8%. Is now the time to buy Artivion? Access our full analysis report here, it’s free.
• Surgical Equipment & Consumables - Specialty company Intuitive Surgical (NASDAQ:ISRG) fell 3.2%. Is now the time to buy Intuitive Surgical? Access our full analysis report here, it’s free.
• Medical Devices & Supplies - Imaging, Diagnostics company GE HealthCare (NASDAQ:GEHC) fell 3.1%. Is now the time to buy GE HealthCare? Access our full analysis report here, it’s free.
• Surgical Equipment & Consumables - Specialty company LeMaitre (NASDAQ:LMAT) fell 3.1%. Is now the time to buy LeMaitre? Access our full analysis report here, it’s free.
• Medical Devices & Supplies - Specialty company Globus Medical (NYSE:GMED) fell 3.2%. Is now the time to buy Globus Medical? Access our full analysis report here, it’s free.

Zooming In On Intuitive Surgical (ISRG)

Intuitive Surgical’s shares are not very volatile and have only had 6 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful, although it might not be something that would fundamentally change its perception of the business.

The biggest move we wrote about over the last year was 5 months ago when the stock gained 16.4% on the news that the company reported strong third-quarter 2025 results that surpassed Wall Street's expectations on both the top and bottom lines. 

The medical technology company announced revenue of $2.51 billion, a significant 22.9% increase compared to the same period last year and comfortably ahead of the $2.41 billion analysts had forecasted. Profitability was also a bright spot, with adjusted earnings per share (EPS) coming in at $2.40, a 20.7% beat over consensus estimates of $1.99. Furthermore, the company demonstrated improved efficiency, as its operating margin expanded to 30.3% from 28.3% in the prior year's quarter. The robust performance, highlighted by strong growth and better-than-expected profits, fueled investor optimism and sent the shares higher.

Intuitive Surgical is down 19.3% since the beginning of the year, and at $453.38 per share, it is trading 23.5% below its 52-week high of $592.85 from January 2026. Despite the year-to-date decline, investors who bought $1,000 worth of Intuitive Surgical’s shares 5 years ago would now be looking at an investment worth $1,879.

ALSO WORTH WATCHING: Nvidia’s Quiet Partner. Nvidia’s chips cost a hundred grand. The connectors that make them work cost even more. One company makes them all.

Every AI server needs specialized infrastructure the chip companies don’t make. High-speed cables. Power connectors. Thermal sensors. This 90-year-old company built a monopoly on it. The AI boom just started. This stock is still flying under the radar. Claim The Stock Ticker Here for FREE.